Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
2 intermediate papers

Works of Claudia Cippitelli being referenced

Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
2018

Author Peers

Author Last Decade Papers Cites
Claudia Cippitelli 116 110 124 168 142 13 387
Luis Samayoa 119 117 170 285 123 16 443
Kinji Itoh 77 144 147 97 91 9 402
Samuel F. Gilbert 87 154 120 240 101 14 417
Qinglong Hu 71 211 153 48 110 10 445
Sandeep Reddy 43 154 144 134 215 18 439
Ornella Gottardi 42 94 103 149 230 11 393
Jennifer B. Goldstein 69 84 173 126 339 17 428
Alberto Achille 133 96 239 86 230 11 418
Elisa Varriale 54 68 113 165 183 14 344
Kim McManus 98 120 94 123 103 10 389

All Works

Loading papers...

Rankless by CCL
2026